The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms
治疗性单克隆抗体 Bamlanivimab 不会通过 FcR 介导的机制增强 SARS-CoV-2 感染
期刊:Pathogens
影响因子:3.3
doi:10.3390/pathogens12121408
Robert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, Shawn Berens, Jamie Blackbourne, Ling Liu, Xiaohua Wu, Jonathan Tetreault, Carter Dodd, Ramtin Sina, Derrick R Witcher, Deanna Newcomb, Denzil Frost, Angela Wilcox, Viktoriya Borisevich, Krystle N Agans, Courtney Woolsey, Abhishek N
